News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln, page-6

I’m starting to actually see value in API at the moment. I sort of disagree with the idea of CPI growth
i think API is certainly well positioned to take advantage of a gigantic growing market.
with ageing populations, the unearthing of new medication to treat newly diagnosed disorders/diseases/ailments growth is a likely outcome.
additionally I also see continued growth in cosmetics/skin care. Again new treatments, growth in both the male/female sector and growing population.
currently attractive yields
i dug deep into API a few years ago at around the $0.60 mark, and rode it like pharlap to $2 before ultimately believing it was overpriced. I feel it’s consolidated and it is looking tempting again for the next run.
API could probably make bank just selling hair dye to grey nomads.
i see $1.30 as the lower end of the trading range and I’m more than happy to get some if I can free up some equity & of course if the timing and price align.
I will research further as my knowledge is slightly out of date with all the fundamentals, but I can’t believe I’d be able to disprove my theory of API and a $1bil MC. Price target has got to be $2.50 I’ll give it 2-3 years.